back to resources Pitango November Newsletter Pitango November 18, 2025 Here’s your full roundup of what’s been happening inside our portfolio, from fundings to founder insights to community spotlights. Pitango | $300M across early-stage and healthcare VC funds Pitango First and Pitango HealthTech proudly share a raise of $300M in new early-stage funds, strengthening support to founders shaping the future of AI, quantum, cybersecurity, cloud, healthtech and life sciences. Via IPO | $493M Raised, $3.65B Valuation Via’s public debut on the New York Stock Exchange is a proud milestone for Israeli innovation and a defining moment for mobility infrastructure. With $493M raised and a $3.65B valuation, Via is now a public company on the move. PsiQuantum | $1B Series E Quantum computing at scale is getting closer. PsiQuantum raised $1B to accelerate its development of a million-qubit, fault-tolerant quantum computer, an ambitious leap forward in computing power. Restore Medical | $23M Series B Pitango HealthTech co-led Restore Medical’s latest round to support the commercialization of its transcatheter heart failure therapy. The team is working on one of medtech’s most pressing challenges with a minimally invasive approach. LeaFix Medical Joins Pitango HealthTech Founded by the team behind Innovalve, LeaFix is tackling mitral valve repair with a new transcatheter device built to deliver meaningful clinical impact. We’re excited to welcome them to the HealthTech portfolio. GammaTime | $14M Seed Round Premium storytelling is going short-form. GammaTime raised $14M to launch high-production-value microdramas designed for the next generation of mobile-native entertainment. Amnon Shashua (AI21 Labs, AAI Technologies) Congrats on being named to TIME’s Top 100 AI Influencers for global impact through AI-driven innovation. Or Perry (StreamElements) on turning a market need into a defining platform: “Don’t just fill a gap. Build the company that transforms it.” Orr Inbar (QuantHealth) on embracing ambiguity: “I’m comfortable being uncomfortable. It’s a breeding ground for ideas and innovation.” Chemi recently published new essays exploring two strategic frontiers for startups: dual-use technology and B2G go-to-market. Jonathan Glazer, MD (Pitango HealthTech) joined the 6:6:9 Podcast to reflect on decision-making under pressure, from the battlefield to the boardroom, and how that shapes healthcare investing today. Yair Cassuto was on the תקציר מנהלים podcast to discuss founder-led M&A, building relationships with buyers early, and scaling through smart exits. AI in Action Our latest showcase featured real-time demos of AI transforming everything from product development to engineering workflows. Read more HealthTech Founders Community Launch We officially launched a new community for HealthTech founders, starting with deep-dive sessions on picking the right business model from the outset. Join here Let Your Data Tell the Story Our hands-on storytelling workshop helped founders sharpen their pitches, clarify their vision, and take control of the room. Read more That’s all from us at Pitango for this month. See you in our next newsletter! Return to Top | Subscribe for Updates back to resources